Skip to main content
. 2022 Sep 7;14(4):328–331. doi: 10.4103/ua.ua_187_21

Table 2.

Disease course of patient with persistent leukocytosis and anemia

Patients Age (years) Sex Clinical stage Histology Survival after leukocytosis and anemia (days) Treatment
1 67 Female T2bN0M0 Urothelial 67 Cystectomy
2 39 Female T4aN0M0 Urothelial 12 Chemoradiation
3 59 Male T2N0M0 Urothelial 138 TURBT
4 57 Male T4N2M1 Urothelial 14 Chemoradiation
5 60 Male T4aN0M0 Urothelial 57 TURBT + chemoradiation
6 63 Male T4aN3M0 Urothelial 17 TURBT + chemoradiation
7 43 Male T4aN1M0 Urothelial 278 TURBT
8 53 Male T4aN0M0 Urothelial 12 TURBT
9 61 Female T2N0M0 Urothelial 214 TURBT + chemoradiation
10 54 Female T4bN1M0 Urothelial 20 Chemoradiation
11 37 Female T4bN1M1 Mixed 12 Chemoradiation
12 57 Male T4aN0M1 Urothelial 14 Cystectomy
13 64 Male T2N1M0 Mixed 74 Cystectomy

TURBT: Transurethral resection of bladder